The superior resistance of some strains of mice over others to infection with certain intraceUular pathogens, including the vaccine strain of Mycobacterium bovis, bacillus Calmette Guerin (BCG), is determined by a gene associated with a small segment of chromosome 1 designated the Ity/Lsh/Bcg locus, referred to here as the Bcg locus. DBA/2 mice containing the dominant resistant allele of the Bcg gene (Bcg'), major histocompatibility complex-compatible BALB/c mice containing the recessive susceptible allele (Bcg~), and congenic C.D2-N20 Bcg', which are genetically the same as BALB/c mice except for possessing a small piece of DBA/2 chromosome 1 containing the Bcg locus, were used to determine whether the Bcg gene determines resistance to infection with the virulent H37P,.v strain of Mycobacterium tuberculosis (Mtb). According to the survival times of Bcg" and B~ mice infected via either the intravenous or respiratory route, Bcg" mice proved much less, rather than more, resistant to Mtb infection than Bcg' mice.
S
ome strains of mice show a higher level of natural resistance than others to infection with certain pathogens, including Salmonella typhimurium, Leishmania donovani, and the attenuated bacillus Calmette Guerin (BCG) ~ strain of Mycobacterium bovis (1) . The genes responsible for resistance to each of these three pathogens have been mapped independently to a small region of chromosome 1 designated the Ity/Lsh/Bcg locus (2--4) , and referred to here as the Bcg locus. It is generally believed that resistance to all of the pathogens mentioned is under the control of a single dominant gene. According to a number of studies, the gene is expressed in macrophages (5-7), and its dominant resistant allele provides these cells with a superior innate capacity to kill microbial pathogens or restrict their intraceUular growth before the generation of specific host immunity.
A knowledge of the genetic and physical intervals defining the Bcg locus of mouse chromosome 1 was used re- ural resistance-associated macrophage protein), encodes for a polypeptide that is part of the transmembrane domain of a macrophage-specific membrane protein (8) . Additional studies with a variety ofBCG-resistant (Bcg') and -susceptible (Bcg ~) strains of mice showed anti-BCG resistance to be associated with a nonconservative Gly-169-to-Asp-169 substitution within the predicted transmembrane domain 4 of Nrampl (9) (10) (11) 
Materials and Methods
Animals. Inbred, pathogen-free, 8-wk-old BALB/c (Bcg~), DBA/2 (Bcgg, and CD2F1 (BALB/c • DBA/2) mice were purchased from Trudeau Institute Animal Breeding Facility. Congenic C.D2 Idhb-Ityr-Pep3b (C.D2-N20) Bcg' breeder mice were kindly provided by Dr. Emil Skamene of the Montreal General Hospital Research Institute (Montreal, Quebec, Canada). These mice differ from BALB/c mice in possessing a small segment of chromosome 1 of DBA/2 mice containing the Bcg locus (13) . All mice were free of common viral pathogens according to the results of routine testing performed by the Research Animal Diagnostic and Investigative Laboratory, University of Missouri, (Columbia, MO).
Mycobacteria. M. tuberculosis H37Rv (TMC #102) was obtained from the Trudeau Mycobacterial Culture (TMC) collection. It was supplied in vials as a frozen (-70~ log phase dispersed culture in Proskauer and Beck medium (Difco Laboratories Inc., Detroit, MI) containing 0.01% Tween 80. For each experiment, a vial was thawed, subjected to 5 s of ultrasound to break up aggregates, and diluted appropriately in PBS containing 0.01% Tween 80. Mice were inoculated with "~10 s CFU of bacilli in 0.2 ml of PBS via a lateral tail vein, or with "5 • 102 CFU by aerosol. Infection by aerosol was performed in a Middlebrook airborne infection apparatus (Tri Instruments, Jamaica, NY). Bacilli were enumerated at progressive times in the lungs, kidneys, livers, and spleens of infected mice by preparing homogenates of these organs in PBS containing 0.05% Tween 80 and plating 10-fold serial dilutions of the homogenates on enriched agar (Middlebrook 7H11; Difco Laboratories Inc.). Colonies were enumerated after 3-4 wk of incubation at 37~
Histology. Pieces of lungs were taken at day 70 of infection and fixed in 10% phosphate-buffered formalin. The tissues were then dehydrated and wax embedded according to routine procedures. Sections 4-6 ~m thick were stained with Ziehl Nielsen stain for acid-fast bacilli and counterstained with methylene blue. Photomicrographs were taken with a microscope (Microphot-Fx; Nikon Inc., Melville, NY).
Results

Bcg' Mice Are Much More Susceptible than Bc~ Mice to Mtb
Infection Initiated Intravenously or by Aerosol. In the first experiments, DBA/2 (Bcg 9 and MHC-compatible BALB/c (Bcg 9 mice were infected with 10 s Mtb intravenously or with 5 X 102 Mtb by aerosol, and growth of the organism in lungs, livers, spleens, and kidneys was followed over a 100-d period. Additional mice were infected to obtain survival data. The results in Fig. 1 show that, in the case of infection via the intravenous route, Bcg r mice were substantially less, rather than more, capable than Bcg ~ mice of controlling the growth of Mtb in their lungs, in that the former mice had ,'-~100 times more bacilli in this organ than the latter on day 100 of infection. Both strains of mice were similar, on the other hand, in terms of their ability to stabilize infection in other organs. It can be seen with both strains of mice that, after a brief period of bacillary growth in the liver, spleen, and kidneys, infection was stabilized and caused to plateau until day 100. This superior resistance of BALB/c mice was independent of the size of inoculum. Thus, DBA/2 mice inoculated intravenously with 103 CFU of Mtb H37Rv contained 2.5 logs more bacilli in their lungs than BALB/c mice inoculated with the same number of bacteria (7.1 + 0.3 log for DBA/2; 4.6 + 0.2 log for BALB/c) at day 80 of infection.
In the case of infection initiated via the respiratory route ( Fig. 2) , Bcg ~ mice were likewise less capable than Bcg ~ mice of controlling Mtb growth in their lungs. However, Bcg ~ mice allowed much less initial seeding of Mtb from the lungs to the liver and spleen. In spite of this, however, Mtb grew more extensively in the livers of these mice than in the livers of Bcg ~ mice a~er day 75 of infection. 
The Superior Anti-Mtb Resistance of BALB/c Mice Is Associated with Slower Development of Lung Pathology. It has been
shown in preceding sections that, in spite of their possession of the susceptibility allele of the Beg gene, BALB/c mice are much more resistant to Mtb infection than DBA/2 mice that contain the dominant resistance allele of the gene, as measured by the ability of the former mice to restrict the growth of Mtb in their lungs and survive infection. Because the difference in anti-Mtb resistance was seen only in the lungs, it was anticipated that the longer survival time of Bcg' mice would be associated with the development of much less lung pathology. This prediction proved correct, as evidenced by the photos of 20-1~m sections of lungs of BALB/c and DBA/2 mice (Fig. 9) , which show that on day 70 of infection the lungs of BALB/c mice displayed fewer and smaller Mtb-induced lesions than the lungs of DBA/2 mice. At higher magnification, the lung lesions in each strain consisted of areas of intense alveolitis in which contiguous air sacs were filled with leukocytes, most of which were mononuclear. Within each lesion, acid-fast bacilli were located in collections of epithelioid macrophages occupying contiguous air sacs. These sites of infection were larger and more numerous in lung lesions of DBA/2 mice (Fig. 9 ) and contained larger numbers of bacilli. A histological examination of the livers and spleens of both strains of mice (not shown) revealed that Mtb infection did not cause progressive pathology. Instead, stabilization of infection in these organs was associated with small compact granulomas that did not change in size or composition over time. This is in keeping with the results of another study in this laboratory (14) . 
Discussion
This study leaves little doubt that the dominant resistant allele of the Bcg gene (Bcg'), which is responsible for the ability of certain strains of mice to better resist the growth of BCG and ce~ain other pathogens during the preimmunity stage of infection, has little or no influence on the ability of these strains to resist infection with virulent Mtb. The results show that Bcg' DBA/2 mice are considerably less, rather than more, resistant to Mtb infection than Bcg* BALB/c mice. This was the case with mice infected either via the respiratory or intravenous route. Superior anti-Mtb resistance of Bcg ~ mice was measured as (a) a longer survival time, (b) a superior ability to control infection in the lung, and (c) slower development of lung pathology. Resistance to Mtb infection was a dominant trait in the F1 progeny of BALB/c and DBA/2 mice, which suggested the possibility that the Bcg ~ rather than the Bcg" allele of the Bcg gene was responsible for resistance to Mtb. However, this proved not to be the case, as evidenced by the finding that Bcg'-congenic C.D2-N20 BALB/c mice were like Bcg ~ BALB/c mice in being more resistant than Bcg' DBA/2 mice to infection with Mtb. Because the recently isolated candidate gene for the Bcg gene, Nramp 1, is contained within the Bcg locus (8) , it follows that Nrampl also has little, if any, influence on resistance to Mtb infection, at least according to the way that anti-Mtb resistance was measured in this study. It needs to be brought to mind, in this connection, that the superior resistance of Bcg" mice to BCG infection has been measured almost exclusively in the spleen as a superior ability to restrict the growth of BCG during the preimmunity first 20 d of infection (15, 16) . On the other hand, it has been shown (17) that Bcg' and Bcg ~ strains of mice are similar in terms of their capacity to restrict preimmunity growth of BCG in other organs. Moreover, both types of mice seem equally capable of resolving BCG infection in all organs from 20 d of infection on, after specific immunity is acquired. Indeed, being an attenuated organism, BCG does not cause progressive disease in any organ of susceptible or resistant mice. In contrast, Mtb causes progressive disease and kills both susceptible and resistant mice. However, as shown here and elsewhere (14, 18) , progressive disease in mice is confined to the lungs. Therefore, tuberculosis in mice is similar to tuberculosis in most humans, in whom the disease is also confined to the lung (19) , in spite of hematogenous dissemination of bacilli to other organs. The results presented here indicating the existence of a gene(s) that makes some strains of mice more capable than others of controlling the growth of virulent Mtb in their lungs and consequently of enabling the mice to survive longer from tuberculosis would seem more relevant to the human situation than a gene that influences the level of resistance against an attenuated organism only in the spleen.
The gene(s) responsible for the superior resistance of BALB/c mice to tuberculosis appears to have little relationship to the recessive Tbc-1 gene described some years ago (20) that makes I/St mice more susceptible to Mtb infection than A/Sn mice. It is almost certain, on the other hand, that MHC genes play a role in determining resistance of different mouse strains to tuberculosis, although pubhshed .papers dealing with this subject are contradictory (21, 22) . MHC genes were not a factor in the results presented here, because the mouse strains used are MHC compatible. In fact, the strains included in this study have been used in most published studies of the genetic basis of anti-BCG resistance and for producing congenic strains possessing the resistant DBA/2 Bcg locus of chromosome 1 (13) . According to a number of in vitro studies (5, 7) the Bcg' allele of the Bcg gene makes macrophages of resistant mice innately more capable of restricting the growth of mycobacteria and of inactivating other microbial pathogens. Presumably, in the case of resistance to BCG, however, this would not apply to liver and lung macrophages, because resistance to BCG infection in these organs is the same in
Bcg" and Bcor mice. Moreover, it is apparent, even in the spleen, that the Bcg gene has a limited influence on the ultimate outcome of infection, in that innate differences in antimicrobial resistance mechanisms between Bcg r and Bcg s macrophages are eventually overridden by additional antimicrobial mechanisms acquired by these cells in response to specific immunity. Indeed, the capacity to generate specific immunity to BCG seems essentially the same in Bcg" and Bcg ~ mice, so far as the ability of mice to resolve infection is concerned. However, this appears not to be the case for resistance to infection with Mtb, as described here. According to our results with BALB/c and DBA/2 mice infected with the same number of Mtb via the respiratory route (Fig. 3) , the superior resistance of the former mice over the latter was seen in the lung after, rather than before, the onset of expression of specific immunity, as evidenced by a substantial reduction in the rate of Mtb growth in this organ from day 20 on. We are aware, however, that immunity to Mtb infection eventually is expressed by macrophages, and that the superior resistance of BALB/c over DBA/2 mice to this pathogen may depend on a superior ability ofBALB/c macrophages to acquire increased mycobactericidal function in response to cytokines secreted by Mtb-specific Tcells. Lastly, it needs to be mentioned that virulence of the H37Rv strain of Mtb for mice is similar to that of the recently isolated C strain that is responsible for a larger number of tuberculosis cases throughout the New York metropolitan area (14) . On the basis of this evidence, it would seem reasonable to assume that H37Rv is still virulent for humans, in spite of its having been isolated >60 yr ago.
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